Immuno-Sensing at Ultra-Low Concentration of TG2 Protein by Organic Electrochemical Transistors

• Published in: Biosensors (Basel) Vol. 13; no. 4; p. 448
• Main Authors: Preziosi, Valentina, Barra, Mario, Villella, Valeria Rachela, Esposito, Speranza, D'Angelo, Pasquale, Marasso, Simone Luigi, Cocuzza, Matteo, Cassinese, Antonio, Guido, Stefano
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 31-03-2023; MDPI
• Subjects: Analysis; Antibodies; Antigens; Apoptosis; Autoimmune diseases; Biosensors; Calcium; Calcium ions; Celiac disease; Cell differentiation; Chemical properties; Crosslinking; Cytosol; Deregulation; diagnostic devices; Disease; Electric properties; Electrochemical analysis; Electrochemistry; Electrodes; Endosomes; Equipment and supplies; Ethanol; Extracellular matrix; Fibrosis; functionalization; GTP-Binding Proteins - metabolism; Identification methods; Immunosensors; Liver; Liver diseases; Localization; Methods; Mitochondria; organic electrochemical transistors; Plasma etching; Protein Glutamine gamma Glutamyltransferase 2; Protein turnover; Proteins; Semiconductor devices; specificity; TG2 protein; Transconductance; Transglutaminase 2; Transglutaminases; Transglutaminases - metabolism; Transistors; Italy; diagnostic devices; functionalization; specificity; TG2 protein; organic electrochemical transistors
• ISSN: 2079-6374; 2079-6374
• DOI: 10.3390/bios13040448

Transglutaminase 2 (TG2) is a ubiquitously expressed member of the transglutaminase family with Ca2+-dependent protein crosslinking activity. Its subcellular localization is crucial in determining its function, and indeed, TG2 is found in the extracellular matrix, mitochondria, recycling endosomes, plasma membrane, cytosol, and nucleus because it is associated with cell growth, differentiation, and apoptosis. It is involved in several pathologies, such as celiac disease, cardiovascular, hepatic, renal, and fibrosis diseases, carrying out opposite functions of up and down regulation in the progression of the same pathology. Therefore, this fine regulation requires a very sensitive and specific method of identification of TG2, which is to be detected in very small quantities in a deregulated condition. Here, we demonstrate the possibility of detecting TG2 down to attomolar concentration by using organic electrochemical transistors driven by gold electrodes functionalized with anti-TG2 antibodies. In particular, a direct correlation between the TG2 concentration and the transistor transconductance values, as extracted from typical transfer curves, was found. Overall, our findings highlight the potentialities of this new biosensing approach for the detection of TG2 in the context of pathological diseases, offering a rapid and cost-effective alternative to traditional methods.